In this week’s bmj ‘Head to Head’ feature, Ben Goldacre, AllTrials.net campaigner, and John Castellani, president and chief executive officer of the Pharmaceutical Research and Manufacturers of America, make the case for change (doi:10.1136/bmj.f1880) and for the status quo, respectively (doi:10.1136/bmj.f1881), as part of the bmj campaign for greater trial data transparency (www.bmj.com/open-data). See Editor’s Choice, US Editor’s Choice, The Shifting Debate on Trial Data Transparency – Edward Davies, US News and Features Editor. http://www.bmj.com/content/347/bmj.f4485
Nothing Personal: Disturbing Undercurrents in Cancer Care
Used in medical education.
Includes referenced discussion sections for evidence-based practice.
- Medical Journalists' Association Open Book Award
"A landmark for the patient voice"
- Macmillan Cancer Support
"A remarkable book... essential reading for all who deal with cancer patients - health professionals, politicians, health service developers, carers and, of course, patients themselves... will surely inspire change."
- Professor Karol Sikora in his foreword.